Zhongguancun announced that its subsidiary Duoduo Pharmaceutical received a “Notice of Acceptance” from the State Drug Administration for Ambroxol Hydrochloride Injection.
中关村：下属公司盐酸氨溴索注射液收到国家药品监督管理局《受理通知书》
Zhongguancun: Subsidiary company ambroxol hydrochloride injection received the “Notice of Acceptance” from the State Drug Administration
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.